Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol

Blood. 2018 Sep 13;132(11):1208-1211. doi: 10.1182/blood-2018-02-834465. Epub 2018 Jul 30.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols* / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols* / adverse effects
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Chemoradiotherapy / adverse effects*
  • Chemoradiotherapy / methods
  • Child
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Etoposide / administration & dosage
  • Etoposide / adverse effects
  • Female
  • Hodgkin Disease* / epidemiology
  • Hodgkin Disease* / therapy
  • Humans
  • Male
  • Pericardial Effusion* / epidemiology
  • Pericardial Effusion* / etiology
  • Prednisone / administration & dosage
  • Prednisone / adverse effects
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Cytarabine
  • Bleomycin
  • Vincristine
  • Etoposide
  • Dexamethasone
  • Cyclophosphamide
  • Cisplatin
  • Prednisone